Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Aug 1;144(2):371-81.
doi: 10.1084/jem.144.2.371.

Regulation by the H-2 gene complex of macrophage-lymphoid cell interactions in secondary antibody responses in vitro

Regulation by the H-2 gene complex of macrophage-lymphoid cell interactions in secondary antibody responses in vitro

C W Pierce et al. J Exp Med. .

Abstract

The ability of antigen-bearing syngeneic and allogeneic peptone-induced peritoneal exudate macrophages to support development of primary and secondary antibody responses by murine lymphoid or spleen cells in vitro has been investigated. The antigen used was the terpolymer of L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). Syngeneic and allogeneic macrophages supported development of comparable primary antibody responses to GAT, indicating that genetic restrictions do not limit efficient macrophage-lymphocyte interactions in primary responses. By contrast, immunized spleen or lymphoid cells developed secondary antibody responses preferentially when stimulated in vitro with GAT on macrophages syngeneic to the macrophages used to present GAT during in vivo immunization. Thus, genetic restrictions regulate efficient macrophage-lymphocyte interactions in secondary antibody responses. These restrictions have been demonstrated from 2 to 8 wk after a single immunization with limiting quantities of GAT and are controlled by the H-2 gene complex. The implications that immune lymphocytes selectively recognize and respond to antigen presented in the context of the macrophage membrane-antigen complex which sensitized the lymphocytes initially are considered.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1973 Nov 1;138(5):1213-29 - PubMed
    1. J Exp Med. 1973 Nov 1;138(5):1121-32 - PubMed
    1. J Exp Med. 1973 Nov 1;138(5):1107-20 - PubMed
    1. J Exp Med. 1973 Apr 1;137(4):967-90 - PubMed
    1. Adv Immunol. 1972;15:95-165 - PubMed

Publication types